Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lactobacillus rhamnosus | 2 | 2018 | 23 | 0.92 | Why? |
| International Agencies | 4 | 2020 | 202 | 0.76 | Why? |
| Clinical Chemistry Tests | 1 | 2018 | 82 | 0.72 | Why? |
| Research Report | 1 | 2021 | 376 | 0.64 | Why? |
| Fatty Acids, Omega-3 | 2 | 2017 | 306 | 0.62 | Why? |
| Potassium | 1 | 2018 | 325 | 0.62 | Why? |
| Autism Spectrum Disorder | 3 | 2019 | 587 | 0.57 | Why? |
| Eczema | 1 | 2018 | 227 | 0.57 | Why? |
| Medical Overuse | 1 | 2017 | 146 | 0.56 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.44 | Why? |
| Alanine Transaminase | 1 | 2017 | 1329 | 0.42 | Why? |
| Probiotics | 1 | 2018 | 694 | 0.42 | Why? |
| Gastrointestinal Tract | 1 | 2018 | 1113 | 0.41 | Why? |
| Evidence-Based Medicine | 3 | 2018 | 3228 | 0.40 | Why? |
| Ferrosoferric Oxide | 2 | 2018 | 19 | 0.36 | Why? |
| Laboratories | 3 | 2020 | 2858 | 0.34 | Why? |
| Laboratories, Hospital | 2 | 2020 | 489 | 0.30 | Why? |
| Dietary Supplements | 2 | 2017 | 2251 | 0.29 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.29 | Why? |
| Reference Values | 2 | 2018 | 795 | 0.29 | Why? |
| Research Design | 2 | 2021 | 5830 | 0.28 | Why? |
| Liver Diseases | 1 | 2017 | 2698 | 0.22 | Why? |
| Containment of Biohazards | 3 | 2020 | 762 | 0.20 | Why? |
| Practice Guidelines as Topic | 5 | 2021 | 15421 | 0.19 | Why? |
| Caseins | 1 | 2017 | 32 | 0.17 | Why? |
| Lactobacillus casei | 1 | 2017 | 24 | 0.17 | Why? |
| Child Nutritional Physiological Phenomena | 1 | 2017 | 40 | 0.17 | Why? |
| Diagnostic Services | 1 | 2018 | 62 | 0.17 | Why? |
| Heterocyclic Compounds | 1 | 2018 | 64 | 0.17 | Why? |
| Hyperkalemia | 1 | 2018 | 140 | 0.17 | Why? |
| Diet, Protein-Restricted | 1 | 2017 | 80 | 0.16 | Why? |
| Ferric Compounds | 1 | 2018 | 136 | 0.16 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.16 | Why? |
| Constipation | 1 | 2017 | 99 | 0.15 | Why? |
| Hematologic Tests | 1 | 2020 | 521 | 0.15 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2017 | 159 | 0.15 | Why? |
| Clinical Decision-Making | 2 | 2021 | 3755 | 0.15 | Why? |
| Risk Management | 2 | 2020 | 1044 | 0.15 | Why? |
| Disease | 1 | 2017 | 126 | 0.15 | Why? |
| Diet, Gluten-Free | 1 | 2017 | 185 | 0.15 | Why? |
| Organometallic Compounds | 1 | 2018 | 206 | 0.15 | Why? |
| Stakeholder Participation | 1 | 2018 | 481 | 0.15 | Why? |
| Cerebrovascular Circulation | 1 | 2018 | 340 | 0.14 | Why? |
| Senna Extract | 1 | 2013 | 1 | 0.14 | Why? |
| Senna Plant | 1 | 2013 | 2 | 0.14 | Why? |
| Folic Acid | 1 | 2016 | 172 | 0.14 | Why? |
| Acinetobacter Infections | 1 | 2017 | 273 | 0.13 | Why? |
| Contrast Media | 2 | 2018 | 1011 | 0.13 | Why? |
| Acinetobacter baumannii | 1 | 2017 | 378 | 0.13 | Why? |
| Cathartics | 1 | 2013 | 41 | 0.13 | Why? |
| Postnatal Care | 1 | 2016 | 346 | 0.12 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.12 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.11 | Why? |
| New Zealand | 1 | 2018 | 2073 | 0.11 | Why? |
| Patient Participation | 1 | 2018 | 829 | 0.11 | Why? |
| Checklist | 1 | 2017 | 714 | 0.11 | Why? |
| Australia | 3 | 2018 | 6306 | 0.11 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.10 | Why? |
| Iron | 1 | 2016 | 619 | 0.10 | Why? |
| Safety Management | 1 | 2018 | 1093 | 0.10 | Why? |
| Albuminuria | 1 | 2010 | 164 | 0.09 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.09 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.09 | Why? |
| Polyethylene Glycols | 1 | 2013 | 574 | 0.09 | Why? |
| Continuity of Patient Care | 1 | 2018 | 1574 | 0.09 | Why? |
| Colon | 1 | 2013 | 669 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.09 | Why? |
| Workplace | 1 | 2020 | 2075 | 0.09 | Why? |
| Colonoscopy | 1 | 2013 | 738 | 0.08 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.08 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.08 | Why? |
| Anti-Bacterial Agents | 2 | 2019 | 10083 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Humans | 30 | 2021 | 930598 | 0.08 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.07 | Why? |
| Prenatal Care | 1 | 2016 | 1314 | 0.07 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.07 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
| Surveys and Questionnaires | 4 | 2020 | 43792 | 0.07 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.07 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.07 | Why? |
| Clinical Laboratory Services | 2 | 2020 | 781 | 0.06 | Why? |
| Communication | 2 | 2018 | 5206 | 0.06 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.06 | Why? |
| Personal Protective Equipment | 3 | 2020 | 15978 | 0.06 | Why? |
| Learning | 1 | 2009 | 1181 | 0.05 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Laboratory Personnel | 1 | 2020 | 126 | 0.05 | Why? |
| Medical History Taking | 1 | 2021 | 350 | 0.05 | Why? |
| Brain | 1 | 2016 | 5133 | 0.05 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.05 | Why? |
| Infant | 2 | 2018 | 30274 | 0.04 | Why? |
| Anthropology, Cultural | 1 | 2018 | 69 | 0.04 | Why? |
| Social Behavior Disorders | 1 | 2017 | 8 | 0.04 | Why? |
| Current Procedural Terminology | 1 | 2017 | 10 | 0.04 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.04 | Why? |
| Ear | 1 | 2017 | 51 | 0.04 | Why? |
| Child | 5 | 2020 | 70012 | 0.04 | Why? |
| Hematinics | 1 | 2017 | 48 | 0.04 | Why? |
| Atlases as Topic | 1 | 2017 | 166 | 0.04 | Why? |
| Renal Elimination | 1 | 2017 | 62 | 0.04 | Why? |
| Health Information Systems | 1 | 2018 | 130 | 0.04 | Why? |
| Communication Disorders | 1 | 2017 | 49 | 0.04 | Why? |
| Bacterial Load | 1 | 2017 | 179 | 0.04 | Why? |
| Perfusion | 1 | 2018 | 254 | 0.04 | Why? |
| Gadolinium | 1 | 2018 | 318 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2017 | 229 | 0.04 | Why? |
| Pathology | 1 | 2018 | 121 | 0.04 | Why? |
| Brain Mapping | 1 | 2018 | 228 | 0.04 | Why? |
| MEDLINE | 1 | 2016 | 76 | 0.04 | Why? |
| Clinical Medicine | 1 | 2017 | 93 | 0.04 | Why? |
| Social Control, Formal | 1 | 2018 | 165 | 0.04 | Why? |
| Comprehension | 1 | 2018 | 259 | 0.04 | Why? |
| Psychomotor Performance | 1 | 2016 | 110 | 0.04 | Why? |
| Proline | 1 | 2017 | 345 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Colistin | 1 | 2017 | 217 | 0.04 | Why? |
| Body Temperature | 1 | 2020 | 875 | 0.03 | Why? |
| Bisacodyl | 1 | 2013 | 1 | 0.03 | Why? |
| Arginine | 1 | 2017 | 377 | 0.03 | Why? |
| Carbapenems | 1 | 2017 | 343 | 0.03 | Why? |
| Focus Groups | 1 | 2018 | 811 | 0.03 | Why? |
| Defecation | 1 | 2013 | 38 | 0.03 | Why? |
| Lactation | 1 | 2016 | 361 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| Quality Assurance, Health Care | 1 | 2018 | 596 | 0.03 | Why? |
| Biological Therapy | 1 | 2017 | 456 | 0.03 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.03 | Why? |
| Child Behavior | 1 | 2016 | 266 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2019 | 1887 | 0.03 | Why? |
| Neurodevelopmental Disorders | 1 | 2016 | 284 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Community Participation | 1 | 2018 | 605 | 0.03 | Why? |
| Internet | 1 | 2009 | 6204 | 0.03 | Why? |
| Policy | 1 | 2018 | 1372 | 0.03 | Why? |
| Metal Nanoparticles | 1 | 2018 | 771 | 0.03 | Why? |
| Medical Informatics | 1 | 2018 | 648 | 0.03 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.03 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.03 | Why? |
| United States | 1 | 2017 | 46150 | 0.02 | Why? |
| Attitude | 1 | 2018 | 1481 | 0.02 | Why? |
| Professional Role | 1 | 2018 | 1280 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2020 | 1956 | 0.02 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2010 | 6166 | 0.02 | Why? |
| Health Personnel | 1 | 2018 | 29646 | 0.02 | Why? |
| Child, Preschool | 3 | 2017 | 36283 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.02 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.02 | Why? |
| Skin | 1 | 2017 | 2096 | 0.02 | Why? |
| Female | 7 | 2020 | 380317 | 0.02 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Diet | 1 | 2016 | 2052 | 0.02 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.01 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.01 | Why? |
| Clinical Protocols | 1 | 2013 | 2734 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Gynecology | 1 | 2009 | 741 | 0.01 | Why? |
| Male | 6 | 2020 | 367725 | 0.01 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.01 | Why? |
| Cluster Analysis | 1 | 2009 | 3001 | 0.01 | Why? |
| Program Evaluation | 1 | 2009 | 1929 | 0.01 | Why? |
| Data Collection | 1 | 2010 | 1769 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Adult | 4 | 2020 | 244371 | 0.01 | Why? |
| Patient Satisfaction | 1 | 2013 | 2517 | 0.01 | Why? |
| Obstetrics | 1 | 2009 | 859 | 0.01 | Why? |
| Netherlands | 1 | 2009 | 3533 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Animals | 2 | 2017 | 78931 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.01 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.01 | Why? |
| Middle Aged | 3 | 2018 | 270681 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| United Kingdom | 1 | 2009 | 18046 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |
| Aged | 1 | 2018 | 215776 | 0.00 | Why? |
Horvath's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_